160 related articles for article (PubMed ID: 22034649)
1. Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis.
Miravitlles M; Kruesmann F; Haverstock D; Perroncel R; Choudhri SH; Arvis P
Eur Respir J; 2012 Jun; 39(6):1354-60. PubMed ID: 22034649
[TBL] [Abstract][Full Text] [Related]
2. Indicators of bacterial infection in patients with acute exacerbation of chronic bronchitis for application in clinical trials of antibacterial drugs.
Burley CJ; Masterton RG; Lovell DP
J Infect; 2007 Sep; 55(3):226-32. PubMed ID: 17640738
[TBL] [Abstract][Full Text] [Related]
3. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
4. Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents.
Niederman MS; Anzueto A; Sethi S; Choudhri S; Kureishi A; Haverstock D; Perroncel R
Respir Med; 2006 Oct; 100(10):1781-90. PubMed ID: 16531032
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
[TBL] [Abstract][Full Text] [Related]
6. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
Querol-Ribelles JM; Molina J; Naberan K; Esteban E; Herreras A; Garcia-de-Lomas J
Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209
[TBL] [Abstract][Full Text] [Related]
7. A multicentre surveillance study on the characteristics, bacterial aetiologies and in vitro antibiotic susceptibilities in patients with acute exacerbations of chronic bronchitis.
Hui DS; Ip M; Ling T; Chang SC; Liao CH; Yoo CG; Kim DK; Yoon HI; Udompanich V; Mogmeud S; Muttalif R; Salleh AM; Roa C; Mendoza M; Fajardo-Ang C; Soepandi P; Isbaniah F; Burhan E; Sudarmono P; Mangunnegoro H; Liu HH
Respirology; 2011 Apr; 16(3):532-9. PubMed ID: 21299688
[TBL] [Abstract][Full Text] [Related]
8. Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease.
Daniels JM; de Graaff CS; Vlaspolder F; Snijders D; Jansen HM; Boersma WG
Clin Microbiol Infect; 2010 Jun; 16(6):583-8. PubMed ID: 19681947
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics in the treatment of acute exacerbations of chronic bronchitis.
Dever LL; Shashikumar K; Johanson WG
Expert Opin Investig Drugs; 2002 Jul; 11(7):911-25. PubMed ID: 12084002
[TBL] [Abstract][Full Text] [Related]
10. Sputum color: potential implications for clinical practice.
Johnson AL; Hampson DF; Hampson NB
Respir Care; 2008 Apr; 53(4):450-4. PubMed ID: 18364056
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
12. Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.
Urueta-Robledo J; Ariza H; Jardim JR; Caballero A; García-Calderón A; Amábile-Cuevas CF; Hernández-Oliva G; Vivar-Orozco R;
Respir Med; 2006 Sep; 100(9):1504-11. PubMed ID: 16504492
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study.
Miravitlles M; Anzueto A; Ewig S; Legnani D; Stauch K
Ther Adv Respir Dis; 2009 Dec; 3(6):267-77. PubMed ID: 19880426
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of sputum gram stain for the determination of appropriate antibiotic therapy in ventilator-associated pneumonia.
Raghavendran K; Wang J; Belber C; Misra SR; Brunton K; Berbary E; Burke MS; Haas CE
J Trauma; 2007 Jun; 62(6):1377-82; discussion 1382-3. PubMed ID: 17563652
[TBL] [Abstract][Full Text] [Related]
16. Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis.
White AJ; Gompertz S; Bayley DL; Hill SL; O'Brien C; Unsal I; Stockley RA
Thorax; 2003 Aug; 58(8):680-5. PubMed ID: 12885984
[TBL] [Abstract][Full Text] [Related]
17. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH
Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization.
Rosón B; Carratalà J; Verdaguer R; Dorca J; Manresa F; Gudiol F
Clin Infect Dis; 2000 Oct; 31(4):869-74. PubMed ID: 11049763
[TBL] [Abstract][Full Text] [Related]
19. Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD.
Anzueto A; Miravitlles M; Ewig S; Legnani D; Heldner S; Stauch K
Respir Med; 2012 Sep; 106(9):1258-67. PubMed ID: 22749710
[TBL] [Abstract][Full Text] [Related]
20. Relation of sputum colour to bacterial load in acute exacerbations of COPD.
Brusse-Keizer MG; Grotenhuis AJ; Kerstjens HA; Telgen MC; van der Palen J; Hendrix MG; van der Valk PD
Respir Med; 2009 Apr; 103(4):601-6. PubMed ID: 19027281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
